These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31199010)

  • 1. Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels.
    Kušnierová P; Zeman D; Hradílek P; Čábal M; Zapletalová O
    J Clin Lab Anal; 2019 Sep; 33(7):e22948. PubMed ID: 31199010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofilament changes in serum and cerebrospinal fluid after acute ischemic stroke.
    Pujol-Calderón F; Portelius E; Zetterberg H; Blennow K; Rosengren LE; Höglund K
    Neurosci Lett; 2019 Apr; 698():58-63. PubMed ID: 30599262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofilaments in Sporadic and Familial Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
    Shahim P; Norato G; Sinaii N; Zetterberg H; Blennow K; Chan L; Grunseich C
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study.
    Vrillon A; Ashton NJ; Karikari TK; Götze K; Cognat E; Dumurgier J; Lilamand M; Zetterberg H; Blennow K; Paquet C
    J Neurol; 2024 Mar; 271(3):1297-1310. PubMed ID: 37950758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    De Schaepdryver M; Jeromin A; Gille B; Claeys KG; Herbst V; Brix B; Van Damme P; Poesen K
    J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):367-373. PubMed ID: 29054919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of neurofilaments in differentiating motor neuron disease from multifocal motor neuropathy.
    Wohnrade C; Seeliger T; Gingele S; Bjelica B; Skripuletz T; Petri S
    J Neurol; 2024 Jul; 271(7):4441-4452. PubMed ID: 38683209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches.
    Wilke C; Pujol-Calderón F; Barro C; Stransky E; Blennow K; Michalak Z; Deuschle C; Jeromin A; Zetterberg H; Schüle R; Höglund K; Kuhle J; Synofzik M
    Clin Chem Lab Med; 2019 Sep; 57(10):1556-1564. PubMed ID: 31251725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study.
    Zucchi E; Bedin R; Fasano A; Fini N; Gessani A; Vinceti M; Mandrioli J
    Neurodegener Dis; 2018; 18(5-6):255-261. PubMed ID: 30428468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofilaments in pre-symptomatic ALS and the impact of genotype.
    Benatar M; Wuu J; Lombardi V; Jeromin A; Bowser R; Andersen PM; Malaspina A
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Nov; 20(7-8):538-548. PubMed ID: 31432691
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Shi J; Qin X; Chang X; Wang H; Guo J; Zhang W
    J Cell Mol Med; 2022 Jan; 26(2):583-587. PubMed ID: 34866307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and cerebrospinal fluid phosphorylated neurofilament heavy protein concentrations in equine neurodegenerative diseases.
    Edwards LA; Donnelly CG; Reed SM; Valberg S; Chigerwe M; Johnson AL; Finno CJ
    Equine Vet J; 2022 Mar; 54(2):290-298. PubMed ID: 33969539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of phosphorylated neurofilament heavy subunit in the cerebrospinal fluid of patients with lumbar spinal stenosis: preliminary findings.
    Ohya J; Chikuda H; Kato S; Hayakawa K; Oka H; Takeshita K; Tanaka S; Ogata T
    Spine J; 2015 Jul; 15(7):1587-92. PubMed ID: 25797810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofilament Levels in CSF and Serum in an Adult SMA Cohort Treated with Nusinersen.
    Rich KA; Fox A; Yalvac M; Heintzman S; Tellez M; Bartlett A; Severyn S; Linsenmayer M; Kelly K; Reynolds J; Sterling GB; Weaver T; Rajneesh K; Pino MG; Arnold WD; Elsheikh B; Kolb SJ
    J Neuromuscul Dis; 2022; 9(1):111-119. PubMed ID: 34776417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease.
    Poesen K; De Schaepdryver M; Stubendorff B; Gille B; Muckova P; Wendler S; Prell T; Ringer TM; Rhode H; Stevens O; Claeys KG; Couwelier G; D'Hondt A; Lamaire N; Tilkin P; Van Reijen D; Gourmaud S; Fedtke N; Heiling B; Rumpel M; Rödiger A; Gunkel A; Witte OW; Paquet C; Vandenberghe R; Grosskreutz J; Van Damme P
    Neurology; 2017 Jun; 88(24):2302-2309. PubMed ID: 28500227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of neurofilament light and heavy chain in spinal muscular atrophy and amyotrophic lateral sclerosis: A pilot study.
    Li JY; Dai Y; Sun XH; Ren HT; Shen DC; Yang XZ; Liu MS; Cui LY
    Brain Behav; 2023 May; 13(5):e2997. PubMed ID: 37070132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome.
    Wang XK; Zhang HL; Meng FH; Chang M; Wang YZ; Jin T; Mix E; Zhu J
    Neurol Sci; 2013 May; 34(5):655-61. PubMed ID: 22526766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS.
    Oeckl P; Jardel C; Salachas F; Lamari F; Andersen PM; Bowser R; de Carvalho M; Costa J; van Damme P; Gray E; Grosskreutz J; Hernández-Barral M; Herukka SK; Huss A; Jeromin A; Kirby J; Kuzma-Kozakiewicz M; Amador Mdel M; Mora JS; Morelli C; Muckova P; Petri S; Poesen K; Rhode H; Rikardsson AK; Robberecht W; Rodríguez Mahillo AI; Shaw P; Silani V; Steinacker P; Turner MR; Tüzün E; Yetimler B; Ludolph AC; Otto M
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(5-6):404-13. PubMed ID: 27415180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation.
    Gaetani L; Höglund K; Parnetti L; Pujol-Calderon F; Becker B; Eusebi P; Sarchielli P; Calabresi P; Di Filippo M; Zetterberg H; Blennow K
    Alzheimers Res Ther; 2018 Jan; 10(1):8. PubMed ID: 29370869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS.
    Benatar M; Zhang L; Wang L; Granit V; Statland J; Barohn R; Swenson A; Ravits J; Jackson C; Burns TM; Trivedi J; Pioro EP; Caress J; Katz J; McCauley JL; Rademakers R; Malaspina A; Ostrow LW; Wuu J;
    Neurology; 2020 Jul; 95(1):e59-e69. PubMed ID: 32385188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated neurofilament heavy chain: a potential diagnostic biomarker in amyotrophic lateral sclerosis.
    Heckler I; Venkataraman I
    J Neurophysiol; 2022 Mar; 127(3):737-745. PubMed ID: 35138963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.